Paolo A. Ascierto

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Publishes on Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management. 1.7k papers and 110.2k citations.

PubIndex Score98Top 2%How it's scored

1.7kPublications

110.2kTotal Citations

First publication: 1997First senior author: 1998

Cancer Immunotherapy and Biomarkers Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management CAR-T cell therapy research Immunotherapy and Immune Responses

Top publicationsby citations

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Grant A. McArthur, Axel Hauschild et al.|New England Journal of Medicine|2011

Cited by 7.7k

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Paolo A. Ascierto, Georgina V. Long et al.|New England Journal of Medicine|2014

Cited by 5.3k

Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma

James Larkin, Antoni Ribas, Paolo A. Ascierto et al.|New England Journal of Medicine|2014

Cited by 2k

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial

Reinhard Dummer, Keith T. Flaherty, Paolo A. Ascierto et al.|The Lancet Oncology|2018

Cited by 1k

Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

Paolo A. Ascierto, James Larkin, Grant A. McArthur et al.|The Lancet Oncology|2016

Cited by 1k